Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non‐gemfibrozil fibrate trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mass changes in remnant cholesterol and LDL cholesterol explain part of the results of gemfibrozil and non‐gemfibrozil fibrate trials

Published:2024-02-11 Issue:5 Volume:295 Page:707-710
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Doi Takahito¹²³,Langsted Anne¹²³^ORCID,Nordestgaard Børge G.¹²³^ORCID

Affiliation:

1. Department of Clinical Biochemistry Copenhagen University Hospital, Herlev and Gentofte Herlev Denmark

2. The Copenhagen General Population Study Copenhagen University Hospital, Herlev and Gentofte Herlev Denmark

3. Faculty of Health and Medical Sciences Institute of Clinical Medicine University of Copenhagen Copenhagen Denmark

Funder

Region Hovedstaden

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13771

Reference10 articles.

1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

2. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

3. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

4. Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease

5. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial;Atherosclerosis;2024-06

2. Therapeutic inhibition of angiopoietin-like protein 3 for hypertriglyceridaemia and residual risk of ASCVD: beginning of the end or end of the beginning?;European Journal of Preventive Cardiology;2024-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3